Published in
Journal of Thoracic Disease, 9(9), p. 3123-3131
Links
Tools
Anti-cancer activity of dose-fractioned mPE +/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
Journal article published in 2017 by
Pierpaolo Pastina,
Valerio Nardone,
Stefania Croci,
Giuseppe Battaglia,
Francesca Vanni,
Cristiana Bellan,
Marcella Barbarino 
,
Veronica Ricci,
Susan Costantini,
Francesca Capone,
Cirino Botta ,
Mayra Rachele Zarone,
Gabriella Misso,
Mariarosaria Boccellino,
Michele Caraglia
and other authors.
,
Veronica Ricci,
Susan Costantini,
Francesca Capone,
Cirino Botta ,
Mayra Rachele Zarone,
Gabriella Misso,
Mariarosaria Boccellino,
Michele Caraglia
and other authors.
